Marker Therapeutics Inc (MRKR)

[lasers]

Yes it can, including infectious disease

Chimeric nucleic acid molecule with non-AUG translation initiation sequences

Abstract
The present disclosure relates to nucleic acid vaccine compositions and methods for preventing or treating pathological conditions, such as cancer or infectious disease. Further, the disclosure provides methods for more efficient production of antigens via mRNA containing one or more non-conventional start codons to promote multiplex initiation of translation in eukaryotic cells.